articleTop 1% cited
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
Urology · 1999 · Vol. 53(3) · pp. 581–589
Claus G. Roehrborn✉(The University of Texas Southwestern Medical Center)Peter Boyle(European Institute of Oncology)A. Lawrence Gould(Merck & Co., Inc., Rahway, NJ, USA (United States))Joanne Waldstreicher(Merck & Co., Inc., Rahway, NJ, USA (United States))
Urinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditionsMedicineProstateRectal examinationUrologyProstate-specific antigenProstate cancerHyperplasiaProstate biopsyBiopsyInternal medicine
MeSH terms
AdultAgedClinical Trials as TopicHumansMaleMiddle AgedPredictive Value of TestsProstatic HyperplasiaSensitivity and SpecificityMulticenter Studies as TopicProstate-Specific Antigen
Citations
388
FWCI
14.94
field-weighted impact
References
25
Percentile
100%
vs. same field & year
Citations per year
Cited by
Benign prostatic hyperplasia: an overview
Urology · 1999 · 438 citations
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction
European Urology · 2015 · 984 citations
References
The Development of Human Benign Prostatic Hyperplasia with Age
The Journal of Urology · 1984 · 2,486 citations
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
Urology · 1996 · 472 citations
Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer
The Journal of Urology · 1992 · 770 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.